Ocular gene therapy
AssigneeGenentech, Inc.
InventorR. Andrew Cuthbertson
Life of this patent
Estimating the term…
Abstract
The invention relates to methods of ocular gene therapy.
Claims11
A method of treating ocular disease comprising incorporating exogenous nucleic acid into an in situ ocular cell under conditions permissive for the uptake of said exogenous nucleic acid, said exogenous nucleic acid encoding a protein associated with said ocular disease, whereby said exogenous nucleic acid is expressed and said disease is treated.
A method of treating ocular disease comprising incorporating exogenous nucleic acid into an in situ ocular cell under conditions permissive for the uptake of said exogenous nucleic acid, said exogenous nucleic acid encoding a protein useful in the treatment of said ocular disease, whereby said exogenous nucleic acid is expressed and said disease is treated.
Dependencies are inferred from the claim text.